These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
423 related items for PubMed ID: 28490868
1. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters. Zou Y, Chen X, Liu J, Zhou DB, Kuang X, Xiao J, Yu Q, Lu X, Li W, Xie B, Chen Q. Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868 [Abstract] [Full Text] [Related]
2. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease. Wang H, Yang T, Li D, Wu Y, Zhang X, Pang C, Zhang J, Ying B, Wang T, Wen F. Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627 [Abstract] [Full Text] [Related]
6. Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation. Wu Y, Qin J, He J, Shen Y, Wang H, Li Y, Zeng Q, Dong J, An Y, Xiong S, Feng M, Wen F. Int J Chron Obstruct Pulmon Dis; 2020; 15():397-407. PubMed ID: 32158205 [Abstract] [Full Text] [Related]
7. Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease. Bade G, Khan MA, Srivastava AK, Khare P, Solaiappan KK, Guleria R, Palaniyar N, Talwar A. Int J Chron Obstruct Pulmon Dis; 2014; 9():759-73. PubMed ID: 25125975 [Abstract] [Full Text] [Related]
8. Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD. Zeng YY, Hu WP, Zuo YH, Wang XR, Zhang J. Int J Chron Obstruct Pulmon Dis; 2019; 14():163-168. PubMed ID: 30655663 [Abstract] [Full Text] [Related]
9. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD. de Moraes MR, da Costa AC, Corrêa Kde S, Junqueira-Kipnis AP, Rabahi MF. Int J Chron Obstruct Pulmon Dis; 2014; 9():735-43. PubMed ID: 25114519 [Abstract] [Full Text] [Related]
10. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers. Singh S, Verma SK, Kumar S, Ahmad MK, Nischal A, Singh SK, Dixit RK. Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680 [Abstract] [Full Text] [Related]
13. Elevated plasma levels of pigment epithelium-derived factor correlated with inflammation and lung function in COPD patients. Li X, Wang T, Yang T, Shen Y, An J, Liu L, Dong J, Guo L, Li D, Zhang X, Chen L, Xu D, Wen F. Int J Chron Obstruct Pulmon Dis; 2015 Apr; 10():587-94. PubMed ID: 25844034 [Abstract] [Full Text] [Related]
14. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease]. Long H, Luo H, Chen P, Li Y. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727 [Abstract] [Full Text] [Related]
15. Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD. Li D, Wu Y, Guo S, Qin J, Feng M, An Y, Zhang J, Li Y, Xiong S, Zhou H, Zeng Q, Chen L, Wen F. Int J Chron Obstruct Pulmon Dis; 2019 Nov; 14():1933-1941. PubMed ID: 31695352 [Abstract] [Full Text] [Related]